BofA reiterated a Buy rating and $30 price target on Progyny (PGNY) after media reported that President Trump is set to announced a new policy initiative aimed at further expanding access to in vitro fertilization. The news is an incremental positive for Progyny, but the actual impact may be more nuanced, the analyst tells investors in a research note. The firm noted the spotlight around IVF is a positive for awareness and may drive some demand for coverage in certain pockets of employers. Given Progyny is a market leader with broad geographic coverage, the company appears well positioned to capture upside if there is in fact a benefit to coverage and utilization, the analyst adds.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
QuantumScape QS -0.65% ▼ , a developer of next-generation solid-state lithium-metal batteries, is set to release its third-quarter 2025 financials after market close on October 22. The stock has rallied nearly 196% year-to-date and 195% over the past year, driven by hopes for its solid-state battery progress and rising interest in EV stocks. While optimism around the company’s technology remains high, analysts are cautious about its valuation after the sharp run-up and prefer to stay on the sidelines for now.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
What to Expect from QS on October 22
Wall Street expects QuantumScape to post a net loss of $0.20 per share, lower than the loss of $0.23 in the year-ago quarter. At the same time, QS is not expected to report any meaningful revenue, as it remains in the pre-commercial stage.
Still, investors will be paying close attention to any updates on battery testing, factory progress, and deals with carmakers. Any positive news in any of these areas could boost investor confidence.
Last week, QuantumScape announced a partnership with Murata ManufacturingMRAAF +5.53% ▲ , a leading Japanese electronics firm. The two companies signed a joint development deal to expand production of ceramic separators used in QuantumScape’s solid-state batteries. These separators are key components that improve battery safety, charging speed, and energy density.
A few weeks earlier, QS also teamed up with Corning GLW -2.57% ▼ to co-develop ceramic separator manufacturing capabilities. The partnership aims to build large-scale production systems to support future commercial battery output.
Together, these agreements have lifted investor confidence, suggesting that QuantumScape is making steady progress toward bringing its solid-state batteries closer to mass production.
Options Traders Anticipate a Large Move
Using TipRanks’ Options tool, we can see what options traders are expecting from the stock immediately after its earnings report. The expected earnings move is determined by calculating the at-the-money straddle of the options closest to expiration after the earnings announcement. If this sounds complicated, don’t worry; the Options tool does this for you.
Turning to Wall Street, analysts have a Hold consensus rating on QuantumScape stock based on one Buy, two Holds, and one Sell assigned in the past three months. At $9.00, the average QS stock price target implies a 46.68% downside potential.
